The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis

Various animal models showed that peroxisome proliferator-activated receptor (PPAR)γ agonists, when given as a gavage shortly preceding colitis induction, protect against inflammatory bowel disease (IBD). We have examined the effects of 16 days rosiglitazone treatment via the diet prior to dextran s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ramakers, Julian D., Verstege, Marleen I., Thuijls, Geertje, Te Velde, Anje A., Mensink, Ronald P., Plat, Jogchum
Format: Artigo
Idioma:Inglês
Publicat: Kluwer Academic Publishers-Plenum Publishers 2007
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1915631/
https://ncbi.nlm.nih.gov/pubmed/17510806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-007-9074-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars